Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ND4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LINC01365 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
STAT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WFDC12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALCA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIBC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928985 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EMID1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO11-LRRC70 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on